Robert Shaw

Employment

• University of Oxford

Education

• Imperial College London MBBS
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (46)

• Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222)
  EBioMedicine 2025 DOI: 10.1016/j.ebiom.2025.105847
  +Save
• MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines
  Science immunology 2025 DOI: 10.1126/sciimmunol.adu3337
  +Save
• Nasally delivered SARS-CoV-2 vaccines: future promise and challenges
  The Lancet Respiratory Medicine 2023 DOI: 10.1016/s2213-2600(23)00383-1
  +Save
• Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
  Journal of Infection 2023 DOI: 10.1016/j.jinf.2023.03.027
  +Save
• Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
  Nature Medicine 2022 DOI: 10.1038/s41591-022-02078-6
  +Save
• Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
  The Lancet Respiratory Medicine 2022 DOI: 10.1016/s2213-2600(22)00163-1
  +Save
• Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
  The Lancet 2021 DOI: 10.1016/s0140-6736(21)01694-9
  +Save
• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
  The Lancet 2021 DOI: 10.1016/s0140-6736(20)32661-1
  +Save
• Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
  Cell 2021 DOI: 10.1016/j.cell.2020.11.020
  +Save
• The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers
  Clinical Infectious Diseases 2021 DOI: 10.1093/cid/ciab004
  +Save